Über uns

MedCom has been founded in 1997 and is an entirely privately-owned company. We offer innovative & advanced imaging-based products with an emphasis on cancer treatment and interventional navigation. All our products are either dedicated to therapy or are motivated by treatment procedures. As an OEM/B2B company, MedCom’s products are integrated by many worldwide acting medical companies.

Our aim

To pioneer each and every product we are working with. Due to our extensive exchange with top members of the research community and some of the world-best physicians, we are permanently exposed to new and upcoming medical needs from the field. As examples, we commercially released 3D ultrasound in 1996, irradiation virtual simulation in 1999, HDR brachytherapy as monotherapy in 2002, fusion imaging in 2003, proton verification in 2004, and transperineal prostate fusion biopsy in 2007. All these – and several other- technologies have been worldwide commercially pioneered by MedCom and belong today to established standards of high-end medical care.

Awards

Over the years MedCom has been awarded several academic and professional awards documenting the appreciation of the community and the quality of our products. MedCom regularly participates in ambitious R&D projects funded by the European Commission, the German Ministry of Research, etc. Joining such leading-edge R&D projects is part of our strategy of permanent innovation and technical leadership.